Obesity Drugs Take Hit; Market Potential Undaunted – Phentermine MedMarket Diligence

    le border=0 width= valign=top cellpadding=2 cellspacing=7>
    Obesity Drugs Take Hit; Market Potential Undaunted
    MedMarket Diligence, CA - Aug 7, 2007
    (orlistat, ,( Phentermine ) a lipase inhibitor), Abbott Laboratories? appetite-suppressant, Meridia (sibutramine), and ( Phentermine ), and generic phentermine for weight reduction.

Tags: , , , ,

Comments are closed.